======= MCC =======
== Gene Information ==
* **Official Symbol**: MCC
* **Official Name**: MCC regulator of WNT signaling pathway
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4163|4163]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P23508|P23508]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MCC&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MCC|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/159350|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a candidate colorectal tumor suppressor gene that is thought to negatively regulate cell cycle progression. The orthologous gene in the mouse expresses a phosphoprotein associated with the plasma membrane and membrane organelles, and overexpression of the mouse protein inhibits entry into S phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Candidate for the putative colorectal tumor suppressor gene located at 5q21. Suppresses cell proliferation and the Wnt/b- catenin pathway in colorectal cancer cells. Inhibits DNA binding of b-catenin/TCF/LEF transcription factors. Involved in cell migration independently of RAC1, CDC42 and p21-activated kinase (PAK) activation (PubMed:18591935, PubMed:19555689, PubMed:22480440). Represses the beta-catenin pathway (canonical Wnt signaling pathway) in a CCAR2-dependent manner by sequestering CCAR2 to the cytoplasm, thereby impairing its ability to inhibit SIRT1 which is involved in the deacetylation and negative regulation of beta-catenin (CTNB1) transcriptional activity (PubMed:24824780). {ECO:0000269|PubMed:18591935, ECO:0000269|PubMed:19555689, ECO:0000269|PubMed:22480440, ECO:0000269|PubMed:24824780}.
|MCC-bdg PDZ|
|negative regulation of epithelial cell migration|
|negative regulation of epithelial cell proliferation|
|negative regulation of canonical Wnt signaling pathway|
|lamellipodium|
|signaling receptor activity|
|negative regulation of Wnt signaling pathway|
|regulation of epithelial cell migration|
|negative regulation of cell migration|
|negative regulation of cell motility|
|regulation of canonical Wnt signaling pathway|
|negative regulation of cellular component movement|
|negative regulation of locomotion|
|regulation of epithelial cell proliferation|
|Wnt signaling pathway|
|cell-cell signaling by wnt|
|regulation of Wnt signaling pathway|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|negative regulation of cell population proliferation|
|regulation of cell migration|
|regulation of cell motility|
|regulation of locomotion|
|regulation of cellular component movement|
|cell-cell signaling|
|negative regulation of multicellular organismal process|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|establishment of protein localization|
|regulation of cell population proliferation|
|negative regulation of response to stimulus|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.77|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.71|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7044
* **Expression level (log2 read counts)**: 2.31
{{:chemogenomics:nalm6 dist.png?nolink |}}